Glow-in-the-Dark drug could slash repeat breast cancer surgeries
Disease control
Terminated
This phase 3 trial tested a drug called PD G 506 A that makes cancer cells glow under a special camera during breast-conserving surgery. The goal was to help surgeons see and remove leftover cancer in real time, reducing the need for a second operation. The study enrolled 57 wome…
Phase: PHASE3 • Sponsor: SBI ALApharma Canada, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC